deltatrials
Unknown PHASE2 INTERVENTIONAL 4-arm NCT02312050

A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes

A Phase 2b, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes

Sponsor: La Jolla Pharmaceutical Company

Conditions Diabetic Chronic Kidney Disease
Interventions GCS-100 Placebo
Updated 7 times since 2017 Last updated: May 16, 2015 Started: Mar 31, 2015 Primary completion: Sep 30, 2016 Completion: Dec 31, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Diabetic Chronic Kidney Disease, this trial is ongoing. The trial is conducted by La Jolla Pharmaceutical Company and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotActive Not Recruiting~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshotActive Not Recruiting~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE2

  5. Jun 2017 — Jun 2018 [monthly]

    Unknown Status PHASE2

    Status: Active Not Recruiting → Unknown Status

▶ Show 2 earlier versions

  1. Feb 2017 — Jun 2017 [monthly]

    Active Not Recruiting PHASE2

  2. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • La Jolla Pharmaceutical Company
Data source: La Jolla Pharmaceutical Company

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations